eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | muscular atrophy |
| Comorbidity | C0024117|chronic obstructive pulmonary disease |
| Sentences | 8 |
| PubMedID- 22518834 | muscle atrophy in chronic obstructive pulmonary disease (copd) is associated with reduced exercise tolerance, muscle strength, and survival. |
| PubMedID- 22031847 | muscle wasting is associated with cancer, sarcopenia, chronic obstructive pulmonary disease, end-stage renal disease, and other chronic conditions and results in significant morbidity and mortality. |
| PubMedID- 24915195 | Background: skeletal muscle wasting commonly occurs in patients with chronic obstructive pulmonary disease (copd) and has been associated with the presence of systemic inflammation and endocrinological disturbance. |
| PubMedID- 25888214 | Our group has previously shown that blood microrna profile reflects muscle phenotype and muscle atrophy in chronic obstructive pulmonary disease (copd) [12,13]. |
| PubMedID- 24666540 | Background: impaired skeletal muscle regeneration could contribute to the progression of muscle atrophy in patients with chronic obstructive pulmonary disease (copd). |
| PubMedID- 19520920 | Skeletal muscle atrophy in individuals with advanced chronic obstructive pulmonary disease (copd) is associated with diminished quality of life, increased health resource use, and worsened survival. |
| PubMedID- 22781565 | Objective: to conduct a preliminary proteomic study of chronic obstructive pulmonary disease (copd) with peripheral skeletal muscle atrophy. |
| PubMedID- 24228729 | Rationale: locomotor muscle atrophy develops in patients with chronic obstructive pulmonary disease (copd) partly because of increased protein degradation by the ubiquitin-proteasome system. |
Page: 1